178 followers
RT @DiabetologiaJnl: The SGLT-2 inhibitor empagliflozin upregulates classical RAS components Ang I and Ang II in type 1 diabetes and demons…
RT @DiabetologiaJnl: The SGLT-2 inhibitor empagliflozin upregulates classical RAS components Ang I and Ang II in type 1 diabetes and demons…
RT @DanielJDrucker: SGLT2i RAS and #T1D @DiabetologiaJnl An alternative avenue fir exploration https://t.co/MtDkl74lx4
RT @DanielJDrucker: SGLT2i RAS and #T1D @DiabetologiaJnl An alternative avenue fir exploration https://t.co/MtDkl74lx4
RT @DanielJDrucker: SGLT2i RAS and #T1D @DiabetologiaJnl An alternative avenue fir exploration https://t.co/MtDkl74lx4